ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Another Anti-PD-L(1) Monoclonal Antibody Filed the IND Application in China to Join the 40+ Applicants! Sales of Keytruda to Rank Second in the World in 2019
November 14, 2019MSD released the Q3 financial report on Oct. 29, 2019. Its figures, especially the figures of its oncology business, were no longer shining, with keywords including Keytruda, Gardasil 9, and China. -
7 anti-PD-(L)1 antibodies in Phase III clinical trials: lung cancer is still an important indication competed for
March 06, 2019Besides the above products mentioned, there are still 7 anti-PD-(L)1 antibodies in Phase III clinical trials, and lung cancer is still one of the important indications the most companies lay out.
Pharma Sources Insight January 2025
